BOSTON BIOKATALYST
CDMO Capabilities
The World’s First Decision-Grade AI Platform for CDMO, CRO, and CMO Matching
Bonjour, le monde. 你好，世界。¡Hola, mundo! Hallo, Welt. Привет, мир. Γεια σου, κόσμε.
Boston BioKatalyst is the first AI-powered platform purpose-built for biomanufacturing execution, not vendor discovery. We combine AI-assisted matchmaking with live program data, human technical oversight, and a curated global CDMO network to route real biotech and pharma programs—not just suggest vendors.
We are the best Ai Powered CDMO CRO Match makers! No Divorces ever!
BioKatalyst is already deployed across 10+ specialized CDMOs, managing $100M+ in active and pipeline programs, with new biotech and pharma teams joining the waitlist daily.
This is not a directory.
This is not a marketplace.
This is execution infrastructure.
Connect with the perfect manufacturing partner. From small molecules to cell therapy, we match you with CDMOs that fit your needs.
AI-Powered CDMO / CRO / CMO Matching, for Biotech/Pharma
Built for real programs, real constraints, real outcomes.
At its core, this is about intelligent alignment—systems finding each other with almost magnetic inevitability. When the right CDMO or CRO locks into the right biotech vision, innovation accelerates, timelines collapse, and life-saving therapies reach the world faster, not by chance, but by design.
BioKatalyst translates complex program requirements into structured, decision-grade matches using AI-assisted scoring layered with human technical judgment.
Unlike algorithm-only platforms, BioKatalyst operates inside a live manufacturing network, learning continuously from execution outcomes, capacity shifts, and regulatory realities.
We take companies from the 0 —-> 1 faster than any gimmick tools online
Our network has already closed $12,000,000+ million worth or programs, with several more RFQS Closing now and match making happening. We have been working in silence, behind the scenes, and finally are public and business has never been better!
Core capabilities include:
- AI-assisted partner scoring and ranking
- Human-in-the-loop validation
- Continuous learning from real program outcomes
- Neutral, non-exclusive routing across the network
Standardized RFQ Intelligence
Apples-to-apples comparisons, not marketing narratives
Unstructured RFQs slow decisions and obscure risk.
BioKatalyst uses a standardized RFQ framework that captures only the inputs that matter for feasibility and manufacturability:
- Target product profile
- Modality and platform requirements
- Critical quality attributes (CQAs)
- Intended scale and timeline
- Assay and stability readiness
- Regulatory pathway and constraints
AI converts these inputs into structured comparison scores across CDMOs, enabling clear, defensible partner selection.
Live Network Execution Data
Matching informed by reality, not static profiles
BioKatalyst integrates live signals from:
- Active RFQs and quotations
- Ongoing GMP programs
- Capacity windows
- Tech-transfer outcomes
- Communication reliability
- Quality posture and regulatory history
This allows matching decisions to reflect current execution reality, not outdated capability claims.
Process Development & Manufacturability Routing
Design for scale from day one
Manufacturing risk is capital risk.
BioKatalyst routes programs to partners aligned with:
- Upstream and downstream process fit
- Scale-down and scale-up strategies
- Analytical depth and method readiness
- Tech-transfer maturity
- Phase-appropriate GMP expectations
Manufacturability is treated as a design constraint, not a downstream problem.
Quality & Regulatory Alignment
Fewer surprises, stronger outcomes
BioKatalyst incorporates quality and regulatory considerations directly into partner matching:
- GMP maturity and inspection history
- QMS robustness
- Data integrity posture
- Validation expectations
- Documentation readiness
This reduces late-stage failures and accelerates regulatory confidence.
Program Coordination & Execution Oversight
One system, one point of accountability
BioKatalyst centralizes:
- Secure data exchange
- NDAs and onboarding
- Partner introductions
- Quote normalization
- Early milestone tracking
Sponsors spend less time coordinating and more time advancing science. CDMOs receive clearer briefs and better-qualified opportunities.
Modalities & Manufacturing Coverage
Routed through a specialized global network
Because BioKatalyst operates as a networked platform, it supports a broad range of modalities through appropriate execution environments:
Biologics & Proteins
mAbs, bispecifics, fragments, fusion proteins, enzymes, cytokines, hormones, scaffolds
Microbial Systems
E. coli, Pichia, Saccharomyces, Bacillus, inclusion bodies, refolding, microbial DSP
Mammalian Systems
CHO, HEK, intensified processes, purification, comparability
Cell & Gene Therapy
AAV, lentiviral, retroviral, plasmid DNA, gene-modified cells
Vaccines & Immunotherapies
Recombinant antigens, VLPs, viral vectors
Nucleic Acids & Emerging Modalities
Plasmid DNA, IVT templates, EVs/exosomes, novel delivery systems (partner-dependent)
Why BioKatalyst wins isn’t because we shout “AI.” and “algorithms” like a third grader.
It’s because we understand intelligence & reality and design systems that follow.
Most competitors build tools. Tools optimize locally, copy patterns, react after the fact. They mistake speed for insight and dashboards for understanding. That’s hobby-grade thinking.
BioKatalyst operates at a different layer. We model the topology of demand itself—the shape of programs, constraints, incentives, timelines, risk, and capability as a living system. We don’t just match CDMOs and CROs to biotech and pharma; we align vectors. When the geometry is right, everything accelerates naturally.
That’s the quiet truth: real intelligence isn’t louder or flashier. It’s more elegant. It collapses complexity instead of adding features. It makes outcomes feel inevitable.
So yes—others play with AI.
We design the system reality moves through.
AI matchmaking only works when embedded inside a living execution network.
BioKatalyst is not learning from hypothetical matches—it is learning from real programs moving through real CDMOs.
That is the difference between recommendation software and infrastructure.
Ready to Get Matched?
BioKatalyst is currently onboarding select biotech, pharma, and CDMO partners.
Join the waitlist to access decision-grade matching and execution routing.